Zhejiang Jingxin Pharmaceutical Co Ltd (002020) — Cash Flow Quality Index
Zhejiang Jingxin Pharmaceutical Co Ltd (002020) has a Cash Flow Quality Index of 1.21x as of September 2025. Operating cash flow of CN¥227.64 Million exceeds net income of CN¥187.73 Million, indicating high earnings quality where cash backs reported profits. Explore 002020 cash flow conversion to assess how effectively this company generates cash.
Cash Flow Quality Index
Operating Cash Flow
Net Income
Data as of
Zhejiang Jingxin Pharmaceutical Co Ltd Cash Flow Quality Index (2002–2025)
Historical Cash Flow Quality Index for Zhejiang Jingxin Pharmaceutical Co Ltd across 23 annual periods. Values consistently above 1.0x indicate high-quality earnings. Check Zhejiang Jingxin Pharmaceutical Co Ltd cash flow reinvestment rate to assess the company's total reinvestment commitment from operating cash flow.
Annual Cash Flow Quality Index for Zhejiang Jingxin Pharmaceutical Co Ltd (2002–2025)
Year-by-year earnings quality comparison for Zhejiang Jingxin Pharmaceutical Co Ltd. For live market cap and the full company financial profile, see Zhejiang Jingxin Pharmaceutical Co Ltd (002020) market capitalisation.
| Year | Quality Index | Operating CF (CNY) | Net Income | YoY Change |
|---|---|---|---|---|
| 2025 | 1.03x | CN¥781.35 Million | CN¥757.98 Million | ▲ +2.1% |
| 2024 | 1.01x | CN¥726.16 Million | CN¥719.13 Million | ▼ -23.7% |
| 2023 | 1.32x | CN¥824.69 Million | CN¥623.42 Million | ▲ +3.2% |
| 2022 | 1.28x | CN¥855.78 Million | CN¥667.82 Million | ▲ +115.8% |
| 2021 | 0.59x | CN¥365.02 Million | CN¥614.70 Million | ▼ -24.4% |
| 2020 | 0.79x | CN¥513.21 Million | CN¥653.33 Million | ▼ -23.4% |
| 2019 | 1.03x | CN¥535.30 Million | CN¥521.95 Million | ▼ -27.2% |
| 2018 | 1.41x | CN¥523.40 Million | CN¥371.49 Million | ▼ -2.3% |
| 2017 | 1.44x | CN¥385.01 Million | CN¥267.03 Million | ▲ +23.7% |
| 2016 | 1.17x | CN¥252.69 Million | CN¥216.73 Million | ▲ +34.3% |
| 2015 | 0.87x | CN¥144.69 Million | CN¥166.62 Million | ▼ -55.8% |
| 2014 | 1.97x | CN¥210.49 Million | CN¥107.08 Million | ▲ +13.9% |
| 2013 | 1.73x | CN¥111.03 Million | CN¥64.35 Million | ▼ -9.3% |
| 2012 | 1.90x | CN¥60.28 Million | CN¥31.68 Million | ▼ -20.2% |
| 2011 | 2.38x | CN¥69.41 Million | CN¥29.12 Million | ▼ -48.1% |
| 2010 | 4.59x | CN¥59.55 Million | CN¥12.96 Million | ▼ -86.5% |
| 2009 | 34.09x | CN¥135.38 Million | CN¥3.97 Million | ▲ +156.6% |
| 2007 | -60.25x | CN¥-87.60 Million | CN¥1.45 Million | ▼ -43530.9% |
| 2006 | -0.14x | CN¥-1.45 Million | CN¥10.47 Million | ▼ -104.1% |
| 2005 | 3.35x | CN¥61.82 Million | CN¥18.45 Million | ▲ +1243.6% |
| 2004 | 0.25x | CN¥6.43 Million | CN¥25.79 Million | ▼ -86.3% |
| 2003 | 1.82x | CN¥46.18 Million | CN¥25.40 Million | ▼ -11.0% |
| 2002 | 2.04x | CN¥45.50 Million | CN¥22.28 Million | — |